Published in Trends Neurosci on July 01, 2001
On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol (2003) 1.77
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev (2008) 1.52
Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol (2007) 1.34
Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem (2009) 1.21
CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol (2007) 1.16
Activation of transcription factor Nrf-2 and its downstream targets in response to moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J Virol (2004) 1.13
Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia. Free Radic Biol Med (2007) 1.08
Induction of cystine-glutamate transporter xc- by human immunodeficiency virus type 1 transactivator protein tat in retinal pigment epithelium. Invest Ophthalmol Vis Sci (2004) 1.07
HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic Biol Med (2010) 1.06
RNA Viruses: ROS-Mediated Cell Death. Int J Cell Biol (2014) 1.01
Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. J Neuroimmunol (2008) 0.98
The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study. Neuroscience (2009) 0.98
CD 4+ T cells in the pathobiology of neurodegenerative disorders. J Neuroimmunol (2009) 0.97
HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1. Cell Death Dis (2013) 0.96
BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells. J Cell Physiol (2009) 0.95
N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction. BMC Neurosci (2007) 0.95
Retrovirus-induced oxidative stress with neuroimmunodegeneration is suppressed by antioxidant treatment with a refined monosodium alpha-luminol (Galavit). J Virol (2006) 0.94
The contribution of peroxynitrite generation in HIV replication in human primary macrophages. Retrovirology (2007) 0.93
Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration. Cellscience (2007) 0.92
HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimers Res Ther (2015) 0.89
Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice. Brain Res (2009) 0.89
Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis. J Neuroimmunol (2010) 0.87
Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Ther (2010) 0.87
Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications. Am J Physiol Regul Integr Comp Physiol (2013) 0.87
Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology (Berl) (2013) 0.86
Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro. J Virol (2006) 0.84
Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. J Virol (2006) 0.84
Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis. PLoS One (2012) 0.84
Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy. Crit Rev Immunol (2013) 0.83
The role of nitric oxide in prostaglandin biology; update. Nitric Oxide (2011) 0.83
The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain. Curr Neuropharmacol (2013) 0.81
HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution. J Neurovirol (2016) 0.81
CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120. PLoS One (2013) 0.81
Neuroprotective effects of the drug GVT (monosodium luminol) are mediated by the stabilization of Nrf2 in astrocytes. Neurochem Int (2010) 0.81
Peroxynitrite decomposition catalyst prevents apoptotic cell death in a human astrocytoma cell line incubated with supernatants of HIV-infected macrophages. BMC Neurosci (2002) 0.80
MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycle. Am J Transl Res (2015) 0.80
Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases. Neuroscience (2012) 0.80
HIV-1 proteins, Tat and gp120, target the developing dopamine system. Curr HIV Res (2015) 0.80
HIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxide. Virol J (2011) 0.79
Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS. Horm Behav (2014) 0.79
Role of nitroso radicals as drug targets in circulatory shock. Br J Pharmacol (2009) 0.78
Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders. Curr HIV Res (2014) 0.78
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line. BMC Neurosci (2009) 0.78
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea. Acta Pharmacol Sin (2012) 0.77
Nicotine mediates expression of genes related to antioxidant capacity and oxidative stress response in HIV-1 transgenic rat brain. J Neurovirol (2015) 0.77
HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5a. Gene Ther (2016) 0.76
Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes. Antioxidants (Basel) (2014) 0.76
Oxidative Stress Is Associated with Neuroinflammation in Animal Models of HIV-1 Tat Neurotoxicity. Antioxidants (Basel) (2014) 0.75
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 14.43
A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem (1993) 3.92
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet (1988) 3.37
Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev (2001) 3.29
In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine. Science (1989) 2.70
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med (1995) 2.11
Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A (1996) 2.02
The neuropathogenesis of HIV-1 infection. J Leukoc Biol (1994) 1.83
BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis (2011) 1.77
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol (1994) 1.56
Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J Biol Chem (1998) 1.55
Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol (1996) 1.55
Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia. Eur J Clin Invest (2000) 1.53
BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ (2003) 1.53
1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity. J Med Chem (1994) 1.50
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochem Biophys Res Commun (1989) 1.46
Mechanisms of HIV-1 to escape from the host immune surveillance. Eur J Clin Invest (2000) 1.46
Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women. HIV Med (2006) 1.43
Interactions between major histocompatibility complex class II surface expression and HIV: implications for pathogenesis. Eur J Clin Invest (2001) 1.42
Hydroxyurea interferes with antigen-dependent T-cell activation in vitro. Eur J Clin Invest (2000) 1.40
Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. Mol Pharmacol (1988) 1.38
Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis (1998) 1.35
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol (1999) 1.34
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. Blood (1991) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol (1996) 1.27
Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int (2007) 1.25
Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation. J Immunol (1985) 1.23
BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia (2004) 1.22
Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol Appl Neurobiol (2000) 1.22
Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A (2000) 1.21
Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes. Biochem Biophys Res Commun (1991) 1.16
Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine. Agents Actions (1991) 1.14
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase. Proc Natl Acad Sci U S A (1992) 1.14
Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br J Pharmacol (1991) 1.14
Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Biochem Biophys Res Commun (1996) 1.13
Initial clinical experience with dideoxynucleosides as single agents and in combination therapy. Ann N Y Acad Sci (1990) 1.12
Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future. Blood (1991) 1.12
Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J (2000) 1.11
Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am J Physiol Cell Physiol (2001) 1.10
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Natl Acad Sci U S A (1999) 1.08
Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication. Mol Pharmacol (1996) 1.08
Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. J Leukoc Biol (1997) 1.07
Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene (2008) 1.07
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon. Arch Virol (2011) 1.04
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. Proc Natl Acad Sci U S A (1996) 1.03
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies. J Biol Regul Homeost Agents (1998) 1.02
Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines. Leukemia (2000) 1.02
Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin. Br J Pharmacol (1992) 1.01
Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res (1995) 1.00
Interleukin 1 beta, interleukin 6, tumor necrosis factor alpha, and interleukin 10 responses in peripheral blood mononuclear cells of cynomolgus macaques during acute infection with SIVmac251. AIDS Res Hum Retroviruses (1996) 1.00
Improving adherence to highly active anti-retroviral therapy in Africa: the DREAM programme in Mozambique. Health Educ Res (2005) 1.00
Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells. Cell Death Differ (2004) 1.00
Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis (2000) 0.99
BAG3 controls angiogenesis through regulation of ERK phosphorylation. Oncogene (2012) 0.99
Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol (2001) 0.98
IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J Immunol (1996) 0.98
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol (1993) 0.98
The development of animal model systems for HIV-1 encephalitis and its associated dementia. J Neurovirol (1995) 0.97
Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Br J Pharmacol (2001) 0.97
Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance. Neuroscience (2009) 0.97
An animal model for antilentiviral therapy: effect of zidovudine on viral load during acute infection after exposure of macaques to simian immunodeficiency virus. AIDS Res Hum Retroviruses (1994) 0.96
New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment. J Hosp Infect (2009) 0.96
Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood (1998) 0.96
The activity of hsp90 alpha promoter is regulated by NF-kappa B transcription factors. Oncogene (2007) 0.96
Enhanced expression of fractalkine in HIV-1 associated dementia. J Neuroimmunol (2001) 0.95
Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models. Antiviral Res (1991) 0.95
Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients. Clin Exp Immunol (2003) 0.93
Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l -cysteine. J Immunol (2000) 0.93
Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine. Drug Metab Dispos (1993) 0.93
Antiviral and immunomodulatory properties of new pro-glutathione (GSH) molecules. Curr Med Chem (2006) 0.93
Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol (2001) 0.92
Superoxide: a key player in hypertension. FASEB J (2004) 0.92
Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate. Mol Pharmacol (1990) 0.91
Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV/HIV chimera. AIDS (2000) 0.90
Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin Exp Immunol (2000) 0.90
Clinical implications of HIV dynamics and drug resistance in macrophages. J Biol Regul Homeost Agents (1998) 0.90
Macrophages: a crucial reservoir for human immunodeficiency virus in the body. J Biol Regul Homeost Agents (2001) 0.90
Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides. Gene Ther (2000) 0.89
The potency of acyclovir can be markedly different in different cell types. Life Sci (2001) 0.89
The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells. Br J Pharmacol (1998) 0.89
Activation of human macrophages by amyloid-beta is attenuated by astrocytes. J Immunol (2001) 0.89
Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release. Int J Tissue React (1991) 0.88
An experimental model system for HIV-1-induced brain injury. Adv Neuroimmunol (1994) 0.88
Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease. Ann Neurol (1988) 0.88
Inactivation of animal and human prions by hydrogen peroxide gas plasma sterilization. Infect Control Hosp Epidemiol (2009) 0.88
Potential role of CCR5 polymorphism in the development of AIDS dementia complex. FEMS Immunol Med Microbiol (1999) 0.87
Detection of soluble BAG3 and anti-BAG3 antibodies in patients with chronic heart failure. Cell Death Dis (2013) 0.87
Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy. AIDS Res Hum Retroviruses (2009) 0.87
Respiratory viruses and influenza-like illness: a survey in the area of Rome, winter 2004-2005. Euro Surveill (2006) 0.87
Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions. J Leukoc Biol (2000) 0.87
Antiproliferative and pro-apoptotic activity of novel phenolic derivatives of resveratrol. Life Sci (2007) 0.86
Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur J Pharmacol (2001) 0.86
Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors. Blood (1999) 0.86